Dr Ted Wu is a senior staff specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia; visiting endocrinologist at Dubbo Base Hospital; Honorary Professor at the Shijiazhuang Diabetes Hospital, Hebei, China; the inaugural District Diabetes Lead of Sydney Local Health District.

Dr Ted Wu is a senior staff specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia; visiting endocrinologist at Dubbo Base Hospital; Honorary Professor at the Shijiazhuang Diabetes Hospital, Hebei, China; the inaugural District Diabetes Lead of Sydney Local Health District.

Professor Ronald Ma is Professor and Head of Endocrinology and Diabetes, the Chinese University of Hong Kong. His research focuses on the epidemiology and genetics of diabetes and diabetic complications. Professor Ma has published extensively with H-index of 86 and co-led the Precision Medicine in Diabetes Initiative precision prognosis workgroup.

Dr. Yong Mong Bee is Head and Senior Consultant of the Department of Endocrinology at Singapore General Hospital (SGH), Clinical Associate Professor at Duke-NUS Medical School, and Clinical Director of Data Science at the DCEO's Office (Future Health and Discovery), SGH. After graduating from the National University of Singapore, Dr. Bee completed his specialist training at SGH and undertook advanced training at the Joslin Diabetes Centre in Boston. Over the past two decades, his work has focused on transforming diabetes care through data science, early risk prediction, and preventive health. He leads several major clinical research initiatives. The Pre-DICTED Study demonstrates how structured lifestyle interventions and behavioural economics can prevent the progression from pre-diabetes to Type 2 diabetes. The Diabetes Clinic of the Future develops predictive analytics and digital tools to deliver personalised, proactive care for multi-ethnic Asian populations. The PISCES Study uses novel biomarkers such as NT-proBNP alongside risk engines to detect early heart failure and cardiovascular events in patients with Type 2 diabetes. Dr. Bee also spearheaded the creation of the SingHealth Diabetes Registry, a multi-institutional database supporting quality improvement, clinical research, and data science. Outside the hospital, he serves as President of Diabetes Singapore, leading community efforts to combat the disease nationwide.